0001209191-19-057636.txt : 20191121 0001209191-19-057636.hdr.sgml : 20191121 20191121173714 ACCESSION NUMBER: 0001209191-19-057636 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191119 FILED AS OF DATE: 20191121 DATE AS OF CHANGE: 20191121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stankovic Srdjan R. CENTRAL INDEX KEY: 0001432545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 191238175 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL ROAD CITY: BRANFORD STATE: CT ZIP: 06405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-19 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001432545 Stankovic Srdjan R. C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, STE. 300 SAN DIEGO CA 92130 0 1 0 0 President Common Stock 2019-11-19 4 M 0 6250 A 8187 D Common Stock 2019-11-19 4 S 0 2160 46.41 D 6027 D Restricted Stock Units 2019-11-19 4 M 0 6250 0.00 D Common Stock 6250 18750 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. The reported price in Column 4 is a weighted average price, and includes 2,153 shares sold at $46.41 and 7 shares sold at $46.7644. The restricted stock units vest in four equal annual installments beginning 11/19/2019. /s/ Austin D. Kim, Attorney-in-Fact 2019-11-21